Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Rang in Aktien #41525
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Aktienkurs
$0.05646911
Zuletzt synchronisiert: 2025-05-28
Marktkapitalisierung
$17.31K
Veränderung (1 Tag)
-1.67%
Veränderung (1 Jahr)
0.00%
Land
US
Handel LungLife AI, Inc. (LLAI)

Kategorie

Dividendenrendite-Verlauf für LungLife AI, Inc. (LLAI)
Dividendenrendite (TTM) von LungLife AI, Inc. (Aktienkürzel: LLAI) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für LungLife AI, Inc. (LLAI) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber